Idiopathic Pulmonary Fibrosis Treatment Market

Idiopathic Pulmonary Fibrosis
Treatment Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Idiopathic Pulmonary Fibrosis Treatment Market – Overview
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease distinguished by progressive and irreversible reduction in
lung function characterized by thickening and damaging of the walls of the air sacs (called alveoli). Common
symptoms include, dry cough, gradual onset of shortness of breath, nail clubbing, and fatigue. Other symptoms are
weight loss and muscle and joint pain. Further complications include, hypertension, heart failure, pulmonary embolism
or pneumonia.
Major factors causing damage to the lungs include, acid reflux from stomach, certain viruses such as Epstein Barr virus
and herpes virus or environmental factors such as breathing in dust such as silica dust, asbestos fibers, hard metal dust,
and coal dust. Treatments for idiopathic pulmonary fibrosis (IPF) include, oxygen therapy, pulmonary rehabilitation,
symptom management, and lung transplant. Prescribed antifibrotic drugs include, Pirfenidone and Nintedanib.
The idiopathic pulmonary fibrosis treatment market size is expected to witness significant growth, owing to increasing
geriatric population. According to National Institute of Health’s (NIH), 2015 report, the symptoms of IPF starts
occurring at the age of 50 to 70 in the U.S. Moreover, increasing prevalence of idiopathic pulmonary fibrosis is also
expected to boost the market growth. According to NIH 2015 estimates, the prevalence of idiopathic pulmonary
fibrosis is 13-20 per 100,000 people worldwide.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Idiopathic Pulmonary Fibrosis Treatment Market Taxonomy:
By Drug Type:
●
Pirfenidone
●
Nintedanib
By Formulation:
●
Tablets
●
Soft Capsules
By Distribution Channel
●
Hospital Pharmacy
●
Retail Pharmacy
●
Online Pharmacy
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2466
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Idiopathic Pulmonary Fibrosis Treatment Market: Key Players
●
Biogen.
●
Boehringer Ingelheim.
●
Bristol-Myers Squibb Company.
●
Cipla.
●
F. Hoffmann-La Roche.
●
FibroGen, Inc.
●
Galapagos NV.
●
MediciNova, Inc.
View this report @
https://www.coherentmarketinsights.com/ongoing-insight/idiopathic-pulmonary-fibrosis-treatment-market-2466
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

Lack of awareness and availability of proper treatment is expected to hinder the idiopathic pulmonary fibrosis market growth. According to National Center for Biotechnology Information (NCBI) 2017 report, 54% patients do not receive any antifibrotic treatment in Europe.

Download Report